Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Gastroesophageal Reflux 1

Interventions

Endoscopy, Digestive System 4Esomeprazole 3Biopsy 3YF 476 2Specimen Handling 2Proton Pump Inhibitors 2Lansoprazole 2Endoscopy 2plecanatide 1omeprazole, sodium bicarbonate drug combination 1linaclotide 1ilaprazole 1Surveys and Questionnaires 1Rabeprazole 1Proflavine 1Lysine Acetyltransferase 5 1Gastropexy 1Gastroenterostomy 1Gastric Bypass 1Fundoplication 1Fluorescein 1Endoscopic Mucosal Resection 1Endoscopes 1Diet, Gluten-Free 1Dexlansoprazole 1Anastomosis, Roux-en-Y 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastroesophageal Reflux × ilaprazole × Clear all
NCT02666976 2019-03-22

The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker

Yonsei University

Phase 4 Completed
20 enrolled
Gastrointestinal

Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡